Originally published by our sister publication Infectious Disease Special Edition
With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against hepatitis B virus (HBV), the CDC’s Advisory Committee on Immunization Practices (ACIP) hopes to significantly increase the number of people who are protected against this disease.
Hepatitis B, a liver disease contracted through exposure to HBV found in bodily fluids, is considered